CB 300919
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-14375-5 mg |
| CAS # | 289715-28-2 |
| Pricing | 5 mg, USD $302.0 |
| Biological Activity | CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft[1]. |
| Purity | 98.53% |
| MWt | 584.11 |
| Formula | C₃₂H₃₄ClN₇O₂ |